Prognostic indicators for survival after resection of pancreatic adenocarcinoma*
References (15)
- et al.
Doubts on “curative” resection of pancreatic cancer
Lancet
(1989) - et al.
Is resection appropriate for adenocarcinoma of the pancreas? A cost benefit-analysis
Am J Surg
(1987) - et al.
Decreased morbidity and mortality after pancreaticoduodenectomy
Am J Surg
(1986) The advantages of typass operations over radical pancreaticoduodenectomy in the treatment of pancreatic carcinoma
Surg Gynecol Obstet
(1970)Cancer of the pancreas. 50 years of surgery
Cancer
(1987)- et al.
Improved hospital morbidity, mortality, and survival after the Whipple procedure
Ann Surg
(1987) - et al.
An analysis of the reduced morbidity and mortality rates after pancreaticoduodenectomy
Arch Surg
(1989)
Cited by (767)
Current State and Future Directions of Radiation Therapy for Pancreas Adenocarcinoma
2023, Surgical Oncology Clinics of North AmericaBibliometric analysis of the classic cited papers in the American Journal of Surgery: Citation recapitulates surgical history
2023, American Journal of SurgeryRadiotherapy for Pancreatic Adenocarcinoma: Recent Developments and Advances on the Horizon
2022, Hematology/Oncology Clinics of North AmericaCitation Excerpt :Surgery remains the mainstay of curative intent treatment with complete resection being the goal.4,5 However, approximately 80% of patients are initially either inoperable or borderline operable due to the proximity and involvement of vessels or other critical organs.6 The most common first site of failure after definitive surgery is distant; however, a significant proportion of patients will progress locally with some studies reporting a local failure rate as high as 50% in resected PDAC.7
- *
Presented at the 33rd Annual Meeting of the Society for Surgery of the Alimentary Tract, San Francisco, California May 11–13, 1992.
- 1
From the Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York. Supported in part by the Milton and Bernice Stern Foundation.